Darrell G. Kirch, MD, president and CEO of the Association of American Medical Colleges, delivered the keynote address during the opening session on Saturday. He laid out six key challenges facing health care around the world. Clinicians are best equipped to meet all six.
May 20, 2018
ATS Foundation Honors Donohue for Commitment to Research
James F. Donohue, MD, has spent a lifetime putting patients first. His commitment to them, in combination with his dedication to finding better treatment options for them, has earned him the highest honor bestowed by the ATS Foundation. On Saturday, the Foundation presented Dr. Donohue with the Breathing for Life Award at its 10th Annual Research Program Benefit at the Manchester Grand Hyatt San Diego.
Respiratory Innovation Summit Fills Development Gap
Innovation fosters innovation. That simple connection inspired the first Respiratory Innovation Summit, which launched Saturday during the ATS 2018 International Conference. And ATS President Marc Moss, MD, served as the premiere speaker.
ATS Lauds 3 Scientists at Opening Ceremony
ATS presented its annual Respiratory Health Awards during the opening ceremony on Saturday. George Thurston, MD, received the Public Service Award; Eric D. Bateman, MB, ChB, received the World Lung Health Award; and Yohannes T. Ghebre, PhD, received the Jo Rae Wright Award for Outstanding Science.
Q&A: Trudeau Medalist’s Work Helps Save Newborns
Jeffrey A. Whitsett, MD, recipient of this year’s Edward Livingston Trudeau Medal, spoke with the ATS Daily Bulletin about his research on surfactant production and function in preterm infants, the work he’s doing now, his clinical contributions, and more.
New Therapies Target Mitochondria
There’s a new bad kid on the block driving lung disease, including pulmonary hypertension and inflammatory diseases: dysfunctional mitochondria. Mitochondrial dysfunction as a driver of oxidative injury is not new, but technological advances are helping researchers and clinicians understand just how intimately involved mitochondria can be in disease pathophysiology—and to identify new therapies that target mitochondria.
Reducing Environmental Exposures in the Disadvantaged
A staggering percentage of the world’s population is exposed to unsafe air. Unfortunately, the burden of this generally falls hardest on the poorest communities, which suffer a higher prevalence of lung disease and associated health effects.
Keynote Series: Research and Slow Medicine
The ATS Keynote Series highlights major advances, recent discoveries, significant accomplishments, transformative findings, and important best practices in pulmonary, critical care, and sleep medicine. These state-of-the-art lectures are presented in two sessions at 8:15-9 a.m. each morning during the conference, when no other programming is scheduled.
PAR Helps Patients Live Well
Everyone wants to live their best life. But for those who have a disease or condition that affects their lungs, that can be difficult to do.
Early Career Professionals Get Ahead
While many ATS 2018 attendees have been gearing up for the conference, some have already been hard at work. They came early to participate in programs for early career professionals— the Student Scholars Program, the Resident Boot Camp, and the ATS Fellows Track Symposium.